Human Diagnostics Worldwide (HUMAN), EIKEN CHEMICAL CO., LTD. (EIKEN) and the Foundation for Innovative New Diagnostics (FIND) announced the launch of the first commercially available molecular diagnostic test for the detection of malaria caused by Plasmodium vivax parasites. Malaria-LAMP is a molecular test that works using loop-mediated isothermal amplification (LAMP), developed by EIKEN with exclusive distribution by HUMAN. FIND evaluated the prototype test in collaboration with the Hospital for Tropical Diseases in London, UK, and coordinated in-country clinical performance studies in Colombia and Peru.
Related topics
Topic | Replies | Views | Activity | |
---|---|---|---|---|
WHO approves first mpox diagnostic test for emergency use, boosting global access | 0 | 5 | October 3, 2024 | |
FIND - RFP for product evaluation and optimization of mpox point-of-care tests | 0 | 43 | September 5, 2024 | |
Rapid Molecular Detection of SARS-CoV-2 (COVID-19) Virus RNA Using Colorimetric LAMP | 0 | 573 | March 2, 2020 | |
Diagnostic accuracy of Fujifilm SILVAMP TB LAM test | 0 | 484 | May 5, 2020 | |
Point-of-care diagnostics for G6PD deficiency | 0 | 620 | October 5, 2019 |